These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38585805)

  • 1. Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy model.
    Yao M; Wei Z; Nielsen JS; Kakazu A; Ouyang Y; Li R; Chu T; Scafidi S; Lu H; Aggarwal M; Duan W
    bioRxiv; 2024 Jul; ():. PubMed ID: 38585805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of a Blood-Brain Barrier Penetrating Erythropoietin in a Mouse Model of Tauopathy.
    Yang J; Ou W; Jagadeesan N; Simanauskaite J; Sun J; Castellanos D; Cribbs DH; Sumbria RK
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy.
    Ou W; Yang J; Simanauskaite J; Choi M; Castellanos DM; Chang R; Sun J; Jagadeesan N; Parfitt KD; Cribbs DH; Sumbria RK
    J Neuroinflammation; 2021 Dec; 18(1):312. PubMed ID: 34972522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
    Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
    EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy.
    Makani V; Zhang B; Han H; Yao Y; Lassalas P; Lou K; Paterson I; Lee VM; Trojanowski JQ; Ballatore C; Smith AB; Brunden KR
    Acta Neuropathol Commun; 2016 Sep; 4(1):106. PubMed ID: 27687527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of peripheral cellular senescence on brain aging and cognitive decline.
    Budamagunta V; Kumar A; Rani A; Bean L; Manohar-Sindhu S; Yang Y; Zhou D; Foster TC
    Aging Cell; 2023 May; 22(5):e13817. PubMed ID: 36959691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Aging and a Dual Orexin Receptor Antagonist on Sleep Architecture and Non-REM Oscillations Including an REM Behavior Disorder Phenotype in the PS19 Mouse Model of Tauopathy.
    Kam K; Vetter K; Tejiram RA; Pettibone WD; Shim K; Audrain M; Yu L; Daehn IS; Ehrlich ME; Varga AW
    J Neurosci; 2023 Jun; 43(25):4738-4749. PubMed ID: 37230765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline.
    Bussian TJ; Aziz A; Meyer CF; Swenson BL; van Deursen JM; Baker DJ
    Nature; 2018 Oct; 562(7728):578-582. PubMed ID: 30232451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
    Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
    Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration.
    Gratuze M; Leyns CE; Sauerbeck AD; St-Pierre MK; Xiong M; Kim N; Serrano JR; Tremblay MÈ; Kummer TT; Colonna M; Ulrich JD; Holtzman DM
    J Clin Invest; 2020 Sep; 130(9):4954-4968. PubMed ID: 32544086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice.
    Ogrodnik M; Evans SA; Fielder E; Victorelli S; Kruger P; Salmonowicz H; Weigand BM; Patel AD; Pirtskhalava T; Inman CL; Johnson KO; Dickinson SL; Rocha A; Schafer MJ; Zhu Y; Allison DB; von Zglinicki T; LeBrasseur NK; Tchkonia T; Neretti N; Passos JF; Kirkland JL; Jurk D
    Aging Cell; 2021 Feb; 20(2):e13296. PubMed ID: 33470505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy.
    Brody AH; Nies SH; Guan F; Smith LM; Mukherjee B; Salazar SA; Lee S; Lam TKT; Strittmatter SM
    Mol Neurodegener; 2022 May; 17(1):32. PubMed ID: 35501917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age.
    Islam MT; Tuday E; Allen S; Kim J; Trott DW; Holland WL; Donato AJ; Lesniewski LA
    Aging Cell; 2023 Feb; 22(2):e13767. PubMed ID: 36637079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD): A Pilot Clinical Trial.
    Gonzales MM; Garbarino VR; Marques Zilli E; Petersen RC; Kirkland JL; Tchkonia T; Musi N; Seshadri S; Craft S; Orr ME
    J Prev Alzheimers Dis; 2022; 9(1):22-29. PubMed ID: 35098970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury.
    Parra Bravo C; Krukowski K; Barker S; Wang C; Li Y; Fan L; Vázquez-Rosa E; Shin MK; Wong MY; McCullough LD; Kitagawa RS; Choi HA; Cacace A; Sinha SC; Pieper AA; Rosi S; Chen X; Gan L
    Mol Neurodegener; 2024 Jun; 19(1):51. PubMed ID: 38915105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau protein aggregation is associated with cellular senescence in the brain.
    Musi N; Valentine JM; Sickora KR; Baeuerle E; Thompson CS; Shen Q; Orr ME
    Aging Cell; 2018 Dec; 17(6):e12840. PubMed ID: 30126037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senolytic therapy is neuroprotective and improves functional outcome long-term after traumatic brain injury in mice.
    Wang J; Lu Y; Carr C; Dhandapani KM; Brann DW
    Front Neurosci; 2023; 17():1227705. PubMed ID: 37575310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senescent Microglia Represent a Subset of Disease-Associated Microglia in P301S Mice.
    Ng PY; Zhang C; Li H; Baker DJ
    J Alzheimers Dis; 2023; 95(2):493-507. PubMed ID: 37545233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Rotator Cuff Tears Reveal an Age-Dependent Increase in Markers of Cellular Senescence and Selective Removal of Senescent Cells With Dasatinib + Quercetin Increases Genetic Expression of COL1A1 In Vitro.
    Hawthorne BC; Wellington IJ; Sabitsky JT; Murphy KV; Karsmarski OP; Thomas RO; LeVasseur MR; Mancini MR; Trudeau MT; Gulati S; McCarthy MBR; Cote MP; Xu M; Mazzocca AD
    Arthroscopy; 2024 Jan; 40(1):34-44. PubMed ID: 37356505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Reduction of Senescent Cell Burden Alleviates Focal Radiotherapy-Related Bone Loss.
    Chandra A; Lagnado AB; Farr JN; Monroe DG; Park S; Hachfeld C; Tchkonia T; Kirkland JL; Khosla S; Passos JF; Pignolo RJ
    J Bone Miner Res; 2020 Jun; 35(6):1119-1131. PubMed ID: 32023351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.